Polyphenols: A diverse class of multi-target anti-HIV-1 agents

Current Drug Metabolism

Volumn 14, Issue 4, 2013, Pages 392-413

  Andrae Marobela, Kerstin ^a   Ghislain, Fotso Wabo ^a,b   Okatch, Harriet ^a   Majinda, Runner R T ^a  

^a UNIVERSITY OF BOTSWANA   (Botswana)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

AIDS; Drug development; Flavonoids; Natural products; Non flavonoids

Indexed keywords

ACACETIN; ANTIVIRUS AGENT; APIGENIN; BAICALEIN; BAICALIN; BPRHIV 001; CAFFEIC ACID DERIVATIVE; CATECHIN; CHRYSIN; COUMARIN DERIVATIVE; DAIDZEIN; ENFUVIRTIDE; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FLAVOPIRIDOL; GALLOCATECHIN; GENISTEIN; HINOKIFLAVONE; INDINAVIR; LIGNAN; LUTEOLIN; MYRICETIN; POLYPHENOL DERIVATIVE; QUERCETIN; SCUTELLARIN; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHOHUMOL; XANTHONE DERIVATIVE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOPATHOGENIC EFFECT; DRUG ABSORPTION; DRUG CYTOTOXICITY; DRUG TARGETING; GRAPEFRUIT JUICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LD 50; MOLECULAR DOCKING; NONHUMAN; QUANTUM CHEMISTRY; SYSTEMATIC REVIEW;

ANIMALS; ANTI-HIV AGENTS; DRUG INTERACTIONS; FLAVONOIDS; HIV INFECTIONS; HIV-1; HUMANS; PHENOLS; TANNINS;

EID: 84881633853     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/13892002113149990095     Document Type: Article

References (142)

1. UNAIDS (2011) UNAIDS World AIDS Day Report 2011, Joint United Nations Programme on HIV/AIDS http://www.unaids.org/en/media/unaids/contentassets/ documents/unaidspublication/2011/JC2216-WorldAIDSday-report-2011-en.pdf. accessed 11.8.2012)
2. Richman, D.D.; Marfolis, D.M.; Delaney, M.; Greene, W.C.; Hazuda, D.; Pomerantz, R.J. The challenge of finding a cure for HIV infection. Science, 2009, 232, 1304-1307.
3. Miceli, L.A.; de Souza, A.M.T.; Rodrigues, C.R.; Paixao, I.C.N.P.; Teixeira, V.L.; Castro, H.C. HIV-reverse transcriptase: a potential target for marine products. Rev. Bras. Farmacogn., 2012, 22 (4), 881-888.
4. Wensing, A.M.J.; van Maarseveen, N.M.; Nijhuis, M. Fifteen years of HIV protease inhibitors: raising the barrier to resistance. Antiviral Res., 2010, 85, 59-74.
5. Montagnier, L. 25 years after HIV discovery: prospects for cure and vaccine. Virology, 2010, 397, 248-254.
6. Mehellou, Y.; De Clercq, E. Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go? J. Med. Chem., 2010, 53, 521-538.
7. Singh I.P., Bharate, S.B., Bhutani, K.K. Anti-HIV natural products. Curr. Sci., 2005, 89 (2), 269-290. (Pubitemid 41666823)
8. Cos, P.; Maes, L.; Vlietlinck, A.; Pieters, L. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection - an update (1998-2007). Planta Med., 2008, 74, 1323-1337.
9. Mukhtar, M.; Arshad, M.; Ahmad, M.; Pomerantz, R.J.; Wigdahl, B.; Parveen, Z. Antiviral potentials of medicinal plants. Virus Res., 2008, 131, 111-120. (Pubitemid 351192951)
10. Singh, I.P.; Bodiwala, H.S. Recent advances in anti-HIV natural products. Nat. Prod. Rep., 2010, 27 (12), 1781-1800.
11. Chinsembu, K.C.; Hedimbi, M. Ethnomedicinal plants and other natural products with anti-HIV active compounds and their putative modes of action. International Journal for Biotechnology and Molecular Biology Research, 2010, 1 (6), 74-91.
12. Singh, J.; Kumar, M.; Kumar, V. Plant-derived anti-human deficiency virus (anti-HIV) compounds. Int. J. Nat. Prod. Sci., 2011, 2, 1-9.
13. Singh, J.; Kumar, M.; Kumar, V. Plant-derived anti-human deficiency virus (anti-HIV) compounds. Int. J. Nat. Prod. Sci., 2011, 2, 1-9.
14. Vo, T.S.; Kim, S.K. Potential anti-HIV agents from marine resources: an overview. Marine Drugs, 2010, 8, 2871-2892.
15. Mishra, B. B.; Tiwari, V.K. Natural products: An evolving role in future drug discovery. Eur. J. Med. Chem., 2011, 46, 4769-4807.
16. Yu, D.; Morris-Natschke, S.L.; Lee, K.-L. New developments in natural products based anti-AIDS research. Med. Res. Rev., 2007, 27, 108-132. (Pubitemid 44975188)
17. Lee, K.-H. Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach. J. Nat. Prod., 2010, 73 (3), 500-516.
18. Zha, W.; Liang, G.; Xiao, J.; Studer, E.J.; Hylemon, P.B.; Pandak, W.M.; Wang, G.; Li, X.; Zhou, H. Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages. PLoS ONE, 2010, 5, 1-8.
19. Hupfeld, J.; Efferth, T.; Drug resistance of human immunodeficiency virus and overcoming it by natural products, In Vivo, 2009, 23 (1), 1-6.
20. Pandey, K.B.; Rizvi, S.I. Current understanding of dietary polyphenols and their role in health and disease. Curr. Nutr. Food Sci., 2009, 5, 249-263.
21. Bravo, L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev., 1998, 56, 317-333. (Pubitemid 28532456)
22. Scalbert, A.; Manach, C; Morand, C; Remesy, C. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr., 2005, 45, 287-306. (Pubitemid 41657352)
23. Arts, I.C.W.; Hollman, P.C.H. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr, 2005, 81, 317-325.
24. Stocklet, J.-C; Schini-Kerth, V. Flavonoides alimentaires et santé humaine. Ann. Pharm. Fr., 2011, 69, 78-90.
25. Cushnie, T.P.T.; Lamb, A J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents, 2005, 26, 343-356. (Pubitemid 41483464)
26. Daglia, M. Polyphenols as antimicrobial agents. Curr. Opin. Biotech., 2012, 23, 174-181.
27. Khan, H. M. T.; Ather, A. Potentials of phenolic molecules of natural origin and their derivatives as anti-HIV agents, Biotechnol Annu. Rev., 2007, 13, 223-264. (Pubitemid 47387126)
28. Teixeira, C; Gomes, J.R.B.; Gomes, P.; Maurel, F. Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug. Eur. J. Med. Chem., 2011, 46, 979-992.
29. Karn, J.; Stoltzfus, CM. Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression. Cold Spring Harb. Perspect. Med., 2012, 4: a006916
30. Dewick, P.M. Medicinal Natural Products - A biosynthetic approach. 3rd Edition John Wiley & Sons Ltd: Chichester, 2009.
31. Winkel-Shirley B. Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol, 2001, 126, 485-493. (Pubitemid 32566604)
32. Boots A.W.; Haenen G.R.M.M.; Bast, A. Health effects of quer-cetin: from antioxidant to nutraceutical. Euro. J. Pharmacolol, 2008, 585, 325-337.
33. Crozier, A.; Clifford, M.N.; Ashihara, H. Plant Secondary Metabolites-occurrence, structure and role in human diet. Wiley-Blackwell Publishing: Singapore, 2006.
34. Williams, CA.; Grayer, R.J.). Anthocyanins and other flavonoids. Nat. Prod. Rep., 2004, 21, 538-573.
35. Welch, R.C.; Wu, Q.; Simon, J.R. Recent advances in anthocyanin analysis and characterization. Curr. Annal. Chem., 2008, 4, 75-101.
36. Tapas, A.R.; Sakarkar, D.M.; Kakde, R.B. Flavonoids as nutraceu-ticals: A review. Trop. J. Pharm. Res., 2008, 7 (3), 1089-1099.
37. Havsteen, B. H. The biochemistry and medical significance of the flavonoids. Pharmacol. & Ther., 2002, 96, 67-202. (Pubitemid 35356564)
38. Manash, C; Scalbert, A.; Morand, C; Rémésy, C; Jiménez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79, 727-747. (Pubitemid 41103873)
39. Beecher, G.R. Overview of dietary flavonoids: nomenclature, occurrence and intake. J. Nutr., 2003, 133, 3248S-3254S. (Pubitemid 37222252)
40. Wang, X.J.; Wang, S.; Huang, S. Study on anti-HIV of quercetin derivants in natural products. Chinese Journal of Experimental Traditional Medicine Formulae, 2011, CNKI: SUNZSFX.0.2011-17-083.
41. Rashed, K.; Zhang, X.-J.; Luo, M.-T.; Zheng, Y.-T. Anti-HIV-1 activity of phenolic compounds isolated from Diospyroslotus fruits. Phytopharmacol., 2012, 3(2), 199-207.
42. Tanaka, R.; Tsuji, H.; Yamada, T.; Kajimoto, T.; Amano, F.; Hasegawa, J.; Hamashima, Y.; Node, K.; Takebe, Y. Novel 3a-methoxyserrat-14-en-21β-ol (PJ1) and 3β-methoxyserrat-14-en-21β-ol (PJ2)-curcumin, kojic acid, quercetin, and baicalein conjugates as HIV agents. Bioorgan. Med. Chem., 2009, 17, 5238-5246.
43. Yu, Y.B.; Myashiro, H., Nakamura, N; Hattori, M.; Park, J.C. Effcets of triterpenoids and flavonoids isolated from Alnus firma on HIV-1 viral enzymes, Arch. Pharm. Res., 2007, 30 (7), 820-826.
44. Kim, HJ.; Woo, E.R.; Shin, C.G.; Park, H. A new flavonol glycoside gallate ester from Acer okamotoanum and its inhibitory activity against HIV-1 integrase. J. Nat. Prod., 1998, 61 (1), 145-148. (Pubitemid 28086997)
45. Souza, J.; de Alemeida Santos, H.; Ferreira, M.M.C.; Molfetta, FA.; Camargo, A.J.; Honorio, K.M.; Ferreira da Silva, A.B. (2003) A quantum chemical and statistical study of flavonoid compounds (Flavones) with anti-HIV activity. A quantum chemical and statistical study of flavonoid compounds (flavones) with anti-HIV activity. J. Mol. Struct., 1999, 491, 123-131.
46. Lameira, J.; Medeiros, I.G.; Reis, M.; Santos, A.S.; Alves, C.N. Structure-activity relationship study of flavones compounds with anti-HIV integrase activity: A density functional theory study. Bioorg. Med. Chem., 2006, 14, 7105-7112. (Pubitemid 44403119)
47. Seal, A.; Aykkal, R.; Babu, R.O.; Ghosh, M. Docking study of HIV-1 reverse transcriptase with phytochemicals. Bioinformation, 2011, 5 (10), 430-444.
48. Tao, J.; Hu, Q.; Yang, J.; Li, R.; Li, X.; Lu, C.; Chen, C.; Wang, L.; Shattock, R.; Ben, K. In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidate. Antiviral Res., 2007, 75(3), 227-233. (Pubitemid 46901083)
49. López-Lázaro, M. Distribution and biological activities of the fla-vonoid luteolin. Mini-Rev. Med. Chem., 2009, 9, 31-59.
50. Tewtrakul, S.; Miyashiro, H.; Nakamura, N.; Hattori, M.; Kawahata, T.; Otake, T.; Yoshinaga, T.; Fujiwara, T.; Supavita, T.; Yuenyongsawad, S.; Rattanasuwon, P.; Dej-Adisai, S. HIV-integrase inhibitory substances from Coleus parvifolius. Phytother. Res., 2003, 17 (3), 232-239. (Pubitemid 36406753)
51. Mehla, R.; Bivalkar-Mehla, S.; Chauhan, A. A flavonoid, luteolin, cripples HIV-1 by abrogation of tat function. PLos One, 2011, 6 (11): e27915.
52. Zhang, G.-H.; Wang, Q.; chen, J.-J.; Zhang, X.-M.; Tam, S.-C.; Zheng, Y.-T. The anti-HIV-1 effect of scutellarin. Biochem. Biophys. Res. Commun., 2005, 334, 812-816. (Pubitemid 41033193)
53. Kitamura, K.; Honda, M.; Yoshizaki, H.; Yamamoto, S.; Nakane, H.; Fukushima, M.; Ono, K.; Tokunaga, T. Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res., 1998, 37, 131-140. (Pubitemid 28186303)
54. Wang, Q.; Ding, Z.-H.; Liu, J.-K.; Zheng, Y.-T. Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus. Antiviral Res., 2004, 64, 189-194. (Pubitemid 39506839)
55. Li, B. Q.; Fu, T.; Donhyan, Y.; Mikovits, J.A; Ruscetti, F.W.; Wang, M.J. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem. Biophys. Res. Commun., 2000, 276, 534-538.
56. Ahn, H.C.; Lee, S.Y.; Kim, J.W.; Son, W.S.; Shin, C.G.; Lee, B.J. Binding aspects of baicalein to HIV-integrase. Mol. Cells, 2001, 12 (1), 127-30.
57. Hu, J.Z.; Bai, L.; Chen, D.-G.; Xu, Q.-T.; Southerland, W.M. Computational investigation of the anti-HIV activity of Chinese medicinal formula Three-Huang powder. Interdiscip. Sci., 2010, 2 (2), 151-156.
58. Meselhy, M.R.; El-Mekkawy, Ma, C.; Nakamura, N. Development of anti-HIV agents from natural resources. J. Trad. Med., 2005, 22 S1: 116-128.
59. Critchfield, J.W.; Butera, S.T.; Folks, T.M. Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Res. Hum. Retroviruses, 1996, 12 (1), 39-46. (Pubitemid 26011160)
60. Chao, S.-H.; Fujinaga, K.; Marion, J.F.; Taube, R.; Sausville, E.A.; Senderowiscz, A.M.; Peterlin, B.M.; Price, D. Falavopiridol inhibits P-TEFb and blocks HIV-1 replication. J. Biol. Chem., 2000, 15, 28345-28348.
61. Ali, A.; Ghosh, A.; Nathans, R.S.; Sharova, N.; O'Brian, S.; Cao, H.; Stevenson, M.; Rana, T.M. Identifiaction of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication. Chembiochem., 2009, 10 (12), 2072-2080.
62. Reutrakul, V., Ningnuek, N., Pohmakotr, M., Yoosook, C., Napaswad, C., Kasisit, J., Santisuk, T., Tuchinda, P. Anti HIV-1 flavonoid glycosides from Ochna integerrima. Planta Med., 2007, 73(7), 683-688. (Pubitemid 47066164)
63. Lin, Y.-M.; Anderson, H.; Flavin, M.T.; Pai, Y.-H. S.; Mata-Greenwood, E.; Pengsuparp, T.; Pezzuto, J. M.; Schinazi, R. F.; Hughes, S. H.; Chen, F.-C. In vitro anti-HIV activity of biflavon-oids isolated from Rhus succedanea and Garcinia multiflora. J. Nat. Prod., 1997, 60 (9), 884-888. (Pubitemid 27407568)
64. Zhao, Y.; Jiang, F.; Liu, P.; Chen, W.; Yi, K. Catechins containing a galloyl moiety as potential anti-HIV-1 compounds. Drug Discov. Today, 2012, 17 (11/12), 630-638.
65. Zavery, N.T. Green tea and its polyphenolic catechins: medicinal uses in cancer and non-cancer applications. Life Sci., 2006, 78, 2073-2080.
66. Khan, N.; Mukhtar, H. Tea polyphenols for health promotion. Life Sci., 2007, 81, 519-533. (Pubitemid 47212236)
67. Jiang, F.; Chen, W.; Yi, K.; Wu, Z.; Si, Y.; Han, W.; Zhao, Y. The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors. Clin. Immunol., 2010, 137, 347-356.
68. Tillekeratne, L.M.; Sherette, A.; Grossman Hupe, L.; Hupe, D.; Hudson, R.A. Simplified catechin-gallate inhibitors of HIV-1 reverse trancriptase. Bioorg. Med. Chem. Lett., 2001, 11, 2763-2767. (Pubitemid 32925312)
69. Yamaguchi, K; Honda, M.; Ikigai, H.; Hara, Y.; Shimamura, T. Inhibitory effects of (-) epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res., 2002, 19-34. (Pubitemid 33001552)
70. Liu, S.; Lu, H.; Zhao, Q.; He, Y.; Niu, J.; Debnath, A.K; Wu, S.; Jiang, S. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41. Biochim. Biophys. Acta, 2005, 1723, 270-281. (Pubitemid 40744696)
71. Kawai, K; Tsuno, N; H., Kitayama, J.; Okaji, Y.; Yazawa, K.; Asakage, M.; Hori, N; Watanabe, T.; Takahashi, K; Nagawa, H. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J. Allergy Clin. Immunol., 2003, 112, 951-957. (Pubitemid 37412065)
72. Williamson, M.P., McCormick, T.G., Nance, C.L., Shearer, W.T. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor CD4: Potential for HIV-1 therapy. J. Allergy Clin. Immunol, 2006, 118, 1369-1374. (Pubitemid 44854123)
73. Hamza, A.; Zhan, C.G. How can (-) - epigallocatechin gallate from green tea prevent HIV-infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors. J. Phys. Chem. B., 2006, 110 (6), 2910-2917. (Pubitemid 43342887)
74. Nance, C.L.; Siwak, E.B.; Shearer, W.T. Preclinical development of the green tea catechin epigallocatechin gallate, as an HIV-1 therapy. J. Allergy Clin. Immunol, 2009, 123 (2), 459-465.
75. Hauber, I.; Hohenberg, H.; Holstermann, B.; Hunstein, W.; Hauber, J. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV-infection. Proc. Natl. Acad. Sci. U S A, 2009, 106, 9033-9038.
76. Zhang, H.S.; Wu, T.C.; Sang, W.W.; Ruan, Z. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway. Life Sci., 2012, 90 (19-20), 747-754.
77. Giunta, B.; Obregon, D.; Hou, H.; Zeng, J.; Sun, N.; Nikolic, V.; Ehrhart, J.; Shytle, D.; Fernandez, F.; Tan, J. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-γ: Role of JAK/STAT1 signaling and implications for HIV-associated dementia. Brain Res., 2006, 1123, 216-225. (Pubitemid 44794387)
78. Nath, S.; Bachani, M.; Harshavardhana, D.; Steiner, J.P. Catechins protect neurons against mitochondrial toxinx and HIV proteins via activation of the BDNF pathway. J. Neurovirol., 2012: doi 10.1007/s13365-0122-1.
79. Zhong, Y.; Ma, C.-M.; Shahidi, F. Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives. J. Functional Foods, 2012, 4, 87-93.
80. Yu, M.; Vaijdy, M. A novel retinoic acid, catechin hydrate and mustard oil based emulsion for enhanced cytokine and antibody response against multiple strains of HIV-1 following mucosal and systemic vaccinations. Vaccine, 2011, 29, 2429-2434.
81. Andres, A.; Donovan, S.M.; Kuhlenschmidt, M.S. Soy isoflavones and virus infections. J. Nutr. Biochem., 2009, 20, 563-569.
82. Stantchev, T.S.; Marcovic, I.; Telford, W.G.; Clouse, K.A.; Broder, C.C. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Res., 2007, 123, 178-89. (Pubitemid 46054340)
83. Adams, S.M.; Aksenova, M.V.; Aksenov, MY.; Mactutus, CF.; Booze, R.M. Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat (1-86) exposure. PLos One, 2012, 7 (5): e37540.
84. Ahn, J.H.; Liu Q.; Lee C; Ahn, M.-J.; Yoo, H.-S.; Hwang, Y.B.; Lee, M.K. New pancreatic lipase inhibitor from Broussonetia kanzinoki. Bioorg. Med. Chem. Lett, 2012, 22, 2760-2763.
85. Wu, J.-H.; Wang, X.-H.; Yi, Y.-H.; Lee, K.-H. Anti-AIDS Agents 54. A potent anti-HIV chalcone and flavonoids from Genus Desmos. Bioorg. Med. Chem. Lett., 2003, 13, 1813-1815. (Pubitemid 36561171)
86. Nair, M.P.; Kandaswami, C; Mahajan, S.; Nair, H.N.; Chawda, R.; Shanahan, T.; Schwartz, S.A. Grape seed extract proanthocyanidins downregulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells. Biol. Res., 2002, 35(3-4), 421-431. (Pubitemid 35385677)
87. Yang, J.; Li, L.; Tan, S.; Jin, H.; Qui, J.; Mao, Q.; Li, R.; Xia, C; Jiang, Z.-H.; Jiang, S.; Liu, S. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: Potential applications for the prevention of HIV-1 infection. Fitoterapia, 2012, 83, 348-355.
88. Okuda, T.; Ito, H. Tannins of constant structure in medicinal and food plants-hydrolyzable tannins and polyphenols related to tannins. Molecules, 2011, 16, 2191-2217.
89. Landete, J.M. Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health. Food Res. Int., 2011, 44, 1150-1160.
90. Bedoya, L. M.; Abad, M.J.; Sanchez-Palomino, S.; Alcami, J.; Bermejo, P. Ellagitannins from Tuberaria lignosa as entry inhibitors of HIV. Phytomed., 2010, 17, 69-74.
91. Notka, F.; Meier, G., Wagner, R. Concerted inhibitor activities of Phyllanthus amarus on HIV-1 replication in vitro and ex vivo. Antiviral Res., 2004, 64, 93-102. (Pubitemid 39451787)
92. Uchiumi, F.; Hatano, T.; Ito, H.; Yoshida, T.; Tanuma, S. Transcriptional suppression of the HIV-1 promoter by natural products. Antiviral Res., 2003, 58, 89-98. (Pubitemid 36507226)
93. Olomola, K.; Klein, R.; Lobb, K. A.; Sayed, Y.; Kaye, P. T. Towards a total synthesis of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors. Tetrahedron Lett., 2010, 51, 6325-6328.
94. Trivedi, J. C.; Bariwal, J. B.; Upadhyay, K. D.; Naliapara, Y. T.; Joshi, S. K.; Pannecouque, C.C.; De Clercq, E.; Shah, A. K. Improved and rapid synthesis of new coumarinyl chalcone derivatives and their antiviral activity. Tetrahedron Lett., 2007, 48, 8472-8474. (Pubitemid 350016206)
95. Zhou, T.; Shi, Q.; Chen, C.-H.; Huang, L.; Ho, P.; Morris-Natschke, S.L.; Lee, K.-H. Anti-AIDS agents 85. Design, synthesis, and evaluation of 1R, 2R-dicamphanooyl-3, 3-dimethyldihydroxpyrano-(2, 3-c)xanthen-7(1H)-one (DCX) derivatives as novel anti-HIV agents. Eur. J. Med. Chem., 2012, 47, 86-96.
96. Chiang, C.C.; Mouscadet, J.F.; Tsai, H.J.; Liu, C.T.; Hsu, L.Y. Synthesis and HIV-1 integrase inhibition of novel bis- or tetra-coumarin analogues. Chem. Pharm. Bull. (Tokyo), 2007, 55 (12), 1740-1743.
97. Vlientinck, A.J.; De Bruyne, T.; Aspers, S.; Pieters, L.A. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med., 1998, 64, 97-109. (Pubitemid 28153266)
98. Abd-Elazem, I.S.; Chen, H.S.; Bates, R.B.; Huang R.C.C. Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza. Antiviral Res., 2002, 55, 91-106. (Pubitemid 34655645)
99. Zhu, K.; Cordeiro, M.C.; Atienza, J.; Robinson, W.E.; Chow, S.A. Irreversible inhibition of HIV-1 integrase by dicaffeoylquinic acid. J. Virol., 1999, 73, 3309-3316. (Pubitemid 29135724)
100. Hu, Z.; Dagang, C.; Lanxiang, D.; Southerland, W.M. Prediction of the interaction of HIV-1 Integrase and its dicaffeoylquinic acid inhibitor through molecular modeling approach. Ethnic. Dis., 2010, 20 (1, Suppl. 1), S1-49-9.
101. Suzuki S,; Umezawa T. Biosynthesis of lignans and norlignans. J. Wood Sci., 2007, 53, 273-284. (Pubitemid 47247329)
102. Xia, Y.-M.; Bi, W.-H.; Zhang, Y.-Y. Synthesis of dibenzylbu-tanediol lignans and their anti-HIV, anti-HSV, anti-tumor activities.) J. Chi. Chem. Soc., 2009, 54 (4) 428-431.
103. Singh, J.; Kumar, M.; Kumar, A. Plant derived anti-human immunodeficiency virus (anti-HIV) compounds. Int. J. Nat. Prod. Sci., 2011, 2, 1-9.
104. Chen, M.; Kilgore, N.; Lee, K.-H.; Chen, D.F. Rubrisandrins A and B, lignans and related anti-HIV compounds from Schisandra rubri-flora. J. Nat. Prod., 2006, 69 (12), 1697-1701. (Pubitemid 46144961)
105. Xiao, W.-L., Huang, S.-X.; Wang, R.-R.; Zhong, J.-L.; Gao, X.-M.; He, F.; Pu, J.-X.; La Y.; Zheng, Y.-T.; Zheng, Q.-T.; Sun, H.-D. Nortriterpenoids and lignans from Schisandra pghenanthera. Phytochemistry, 2008, 69, 2862-2866.
106. Li, X.-N.; Pu, J.-X.; Du, X.; Yang, L.-M.; An, H.-M.; Lei, C.; He, F.; Luo, X.; Zheng, Y.-T.; Lu, Y.; Xiao, W.-L.; Sun, H.-D. Lignans with anti-HIV activity from Schisandra propinqua var. sinensis. J. Nat. Prod., 2009, 72, 1133-1141.
107. Pu, J.-X.; Yang, L.-M.; Xia, W.-L.; Li, R.-T; Lei, C.; Gao, X.-M.; Huang, S.-X.; Li, S.-H.; Zhang, Y.-T.; Huang, H.; Sun, H.-D. Compounds from Kadsura heteroclita and related anti-HIV activity. Phytochemistry, 2008, 69(5) 1266-1272.
108. Yang, G.-Y.; Li, Y.K.; Wang, R.-R.; Xiao, W.L.; Yang, M.-L.; Pu, J.-X.; Zheng, Y.-T.; Sun, H.-D. Dibenzocyclooctadiene lignans from the fruits of Schisandra wilsoniana and their anti-HIV-1 activities. J. Asian Nat. Prod. Res., 2010, 12 (6), 470-476.
109. Tan, G.T.; Pezzuto, J.M.; Kinghorn, A.D.; Hughes, S.H. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J. Nat. Prod., 1991, 54, 143-154.
110. Peng, Z.G.; Xu, L.I.; Ye, W.C.; Xiao, P.G.; Chen, H.S. Effective components against HIV-1 replicative enzymes isolated from plants. Yao Xue Xue Bao, 2010, 45(2): 235-40.
111. Roupe, K.A.; Remsberg, CM.; Yáñez, JA.; Davies, N.M. Pharmacometrics of stilbenes: seguing towards the clinic. Curr. Clin. Pharmacol, 2006, 1, 81-101.
112. Lin, H.W.; Sun, M.X.; Wang, Y.H.; Yang, L.M.; Yang, Y.R.; Huang, N.; Xuan, L.J.; Xu, Y.M.; Bai, D.L.; Zheng, Y.T.; Xiao, K. Anti-HIV activities of the compounds isolated from Polygonum caspidatum and Polygonum multiflorum. Planta Med., 2010, 76 (9), 889-92.
113. Lee, E. O.; Kim, S. E.; Park, H. K; Kang, J. L.; Chong Y. H. Extracellular HIV-1 Tat upregulates TNF - a dependent MCP-1/CCL2 production via activation of Erk1/2 pathway in rat hippocampal slice cultures: inhibition by resveratrol, a polyphenolic phytostil-bene. Exp. Neurol., 2011, 229, 399-408.
114. Bedoya, L. M.; Del Olmo, E.; Sancho, R.; Barboza, B.; Beltran, M.; Garcia-Cadenas, A. E.; Sanchez-Palomino, S.; Lopez-Perez, J. L.; Munoz, E.; Feliciano, A. S.; Alcami, J. Anti-HIV activity of stilbene-related heterocyclic compounds. Bioorg. Med. Chem. Lett., 2006, 16, 4075-4079. (Pubitemid 43903202)
115. Pedro M.; Cerqueira F.; Sousa M.E.; Nascimento M.S.J.; Pintoa M. Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. Bioorganic & Med. Chem., 2002, 10, 3725-3730. (Pubitemid 36164676)
116. Magadula, J.J. A bioactive isoprenylated xanthone and other constituents of Garcinia edulis. Fitoterapia, 2008, 81, 420-423.
117. Shohaib, T.; Shafique, M.; Dhanya, N.; Divakar, M.D. Importance of flavonoids in therapeutics. Hygeia J. D. Med., 2011, 3 (1), 1-18.
118. Fraga, C.G. Plant polyphenols: How to translate their in vitro antioxidant actions to in vivo conditions. Life, 2007, 59 (4-5), 308-315. (Pubitemid 46763776)
119. Chung, K.-T.; Wei, C.-I; Johnson, M.G. Are tannins a double edged sword in biology and health? Trends Food Sci. Tech., 1998, 9, 168-175. (Pubitemid 28348659)
120. Leteane, M.M.; Ngwenya, B.N.; Muzila, M.; Namushe, A.; Mwinga, J.; Musonda, R.; Moyo, S.; Mengestu, Y. B.; Abegaz, B.M.; Andrae-Marobela, K. Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in-vitro HIV-1c replication in PBMCs by different modes of action. J. Ethnopharmacol., 2012, 141, 48-56.
121. Klos, M.; van der Venter, M.; Milne, P.J.; Traore, H.N.; Meyer, D.; Oosthuizen, V. In vitro anti-HIV activity of five selected South African medicinal plant extracts. J. Ethnopharmacol., 2009, 124, 182-188.
122. Zhu, M.; Phillipson, J.D.; Greengrass, P.M.; Bowery, N.E.; Cai, Y. Plant polyphenols: Biologically active compounds or non-selective binders to protein. Phytochem., 1997, 44 (3), 441-447. (Pubitemid 27100304)
123. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, N.D.S. A ligand-based approach for the in-silico discovery of multi-target inhibitors for proteins associated with HIV infection. Mol. Biosyst., 2012, 8, 2188-2196.
124. Fink, R.C.; Roschek, B. Jr.; Alberte, R.S. HIV type 1 entry inhibitors with a new mode of action. Antivir Chem. Chemother., 2009, 19 (6), 243-255.
125. Morris, M. E.; Zhang, S. Flavonoiddrug interactions: Effects of flavonoids on ABC transporters. Life Sci., 2006, 78, 2116-2130.
126. Hodek, P.; Trefil, P.; Stiborova, M. Flavonoidspotent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact., 2002, 139, 1-21. (Pubitemid 34135994)
127. Penzak, S. R.; Acosta, E. P.; Turner, M.; Edwards, D. J.; Hon, Y. Y.; Desai, H. D.; Jann, M. W. J. Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics. Clin. Pharmacology, 2002, 42(10), 1165-1170.
128. Demarles, D.; Gillotin, C; Bonaventure-Paci, S; Vincent, I.; Fosse, S.; Taburet, A. M. Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice. Antimicrob. Agents Chemother., 2002, 46(5), 1589-1590. (Pubitemid 34415354)
129. Shelton, M. J.; Mei, H.; Hewitt, R. G.; Defrancesco, R. Effects of grapefruit juice on pharmacokinetic exposure to indinavir in HIV-positive subjects. Antimicob. Agents Chemother., 2001, 45(1), 298-300.
130. Fuhr U. Drug interactions with grapefruit juice. Drug Saf, 1998, 18(4), 251-272.
131. Kupferschmidt, H. H.; Fattinger, K. E.; Ha, H. R.; Follath, F.; Krahenbuhl, S. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. S. Br. J. Clin. Pharmcol., 1998, 45(4) 355-359. (Pubitemid 28138827)
132. Lau, A. J.; Yang, G.; Rajaraman, G.; Baucom, C. C.; Chang T. K. Human pregnane X receptor agonism by Ginkgo biloba extract: assessment of the role of individual ginkgolides. J. Pharmacol. Exp. Ther., 2010, 335(3), 771-80.
133. Heredia, A.; Davis, C.; Redfield, R. Synergistic inhibition of HIV-1 in activated and resting PBMCs, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J. Acquir. Immune Defic. Syndr., 2000, 25 (3), 246-55. (Pubitemid 32010127)
134. Chattopadhyay, D.; Chawla-Sarka, M.; Chatterjee, T.; Dey, R.S.; Bag, P.; Chakraborti, S.; Khan, M.T.H. Recent advancements for the evaluation of anti-viral activities of natural products. N. Biotechnol., 2009, 25 (5), 347-368.
135. Patwardhan, B.; Vaidya, A.D.B. Natural products drug discovery: Accelerating the clinical candidate development using reverse pharmacology approaches. Indian. J. Exp. Biol., 2010, 48, 220-227.
136. Vaidya, A.D.B. Reverse pharmacological correlates of ayurvedic drug actions. Indian J. Pharm., 2006, 38, 4-10.
137. Ong, E. B. B.; Watanabe, N.; Saito, A.; Futamara, Y.; El Galil, K. H. A.; Koito, A.; Najimudin, N.; Osada, H. Vipirinin, a Coumarin-based HIV-1 Vpr Inhibitor, Interacts with a Hydrophobic Region of VPR J. Biol. Chem., 2011, 286, 14049-14056.
138. Lee, J.; Huh, M.S.; Kim, Y.C.; Hattori, M.; Otake, T. Lignans, sesquilignans and dilignans, novel HIV-1 protease and cytopathic effect inhibitors purified from the rhizomes of Saururus chinensis. Antiviral Res., 2010, 85, 425-428.
139. Frankel, A.D.; Young, J.A.T. HIV-1: Fifteen proteins and an RNA. Annu. Rev. Biochem., 1998, 67, 1-25. (Pubitemid 28411121)
140. Han, Q.-B., Xu, H.-X. Caged Garcinia Xanthones: Development Since 1937. Current Med. Chem., 2009, 16, 3775-3796.
141. Reutrakul, V.; Anantachoke, N.; Pohmakotr, M.; Jaipetch, T.; Samaisukh, S.; Yoosoo, C.; Napaswat, C.; Thawatchai, S.; Patoomratana, T. Cytotoxic and anti-HIV-1 caged xanthones from the resin and fruits of Garcinia hanburyi. Planta Med, 2007, 73, 33-40. (Pubitemid 46909849)
142. Groweiss, A.; Cardellina, J.H.; Boyd, M.R. HIV-inhibitory preny-lated xanthones and flavones from Maclura tinctoria. J. Nat. Prod., 2000, 63, 1537-1539.